In contrast, a previous study has discovered that the engineered loss of USP18 increases ISGylation (François-Newton et al., 2011); therefore, upregulated USP18 might reduce ISGylation to inactivate the interferon response, implying the function of ac4C modification in SLE which should be identified in further studies. Here, USP18 is linked to systemic lupus erythematosus.